arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Hyperfine, Inc.

HYPR
$0.95 ▼ -0.03 (-3.40%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
23 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

Hyperfine, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $92.8M
Dividend Yield
Revenue Growth 82.6%
Op. Margin -219.3%
ROIC -18.0%
FCF / Share $-0.09
Trailing P/E
Price / Book 2.7x
FCF Yield
Debt / Equity 0.38
info Valuation on last close. End-of-day price, Aug 7, 2026.

23-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.90M
↑ +82.6%
Net Income Profit after all expenses
$-8.62M
↑ +8.4%
Operating Margin Operating profit as % of sales
-219.3%
↓ -51.4% 0th
FCF / Share Free cash flow per share
$-0.09
↑ +26.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
1
Returns
11
Cash Quality
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 23 quarters